NFB-04. Evaluating focal areas of signal intensity (FASI) in children with neurofibromatosis type-1 (NF1) treated with selumetinib on PBTC-029B

BACKGROUND: Focal Areas of Signal Intensity (FASI) are T2 hyperintense benign lesions in children with NF1. They can mimic the appearance of low-grade glioma (LGG). Selumetinib has shown efficacy in treatment of NF1-associated LGG but treatment effects on FASI have not yet been described. METHODS: P...

Descripción completa

Detalles Bibliográficos
Autores principales: Pillay Smiley, Natasha, Leach, James, Lane, Adam, Hummel, Trent, Fangusaro, Jason, de Blank, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Neurofibromatosis and other Predisposition Syndromes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165296/
http://dx.doi.org/10.1093/neuonc/noac079.468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165296/
http://dx.doi.org/10.1093/neuonc/noac079.468

Ejemplares similares